Monoclonal antibodies (mAbs) bind to quite a lot of targets with excessive affinity and specificity, making them supreme therapeutics. Nevertheless, conventional approaches to antibody screening workflows are labor intensive, time consuming, and solely report snapshots of knowledge. By means of live-cell improvements in antibody discovery applied sciences, drug builders can benefit from the pure variety in antibodies for treating cancers, persistent irritation, and infectious illnesses. The Incucyte® Stay-Cell Evaluation System supplies real-time knowledge and actionable insights in antibody discovery workflows, together with antibody internalization, antibody-dependent mobile phagocytosis (ADCP), antibody-dependent cell-mediated cytotoxicity (ADCC), and antibody-driven immune cell killing.
Obtain this white paper from Sartorius to find
- How Incucyte® Stay-Cell Evaluation Methods present real-time knowledge and actionable insights for routine practical assays in antibody discovery workflows
- Validated assays that change conventional end-point strategies, similar to FACS or ELISA, for kinetic live-cell evaluation throughout the antibody triage course of
- How Incucyte® reagents and assays streamline workflows for routine research in 2D and sophisticated 3D cell fashions
